Personal tools

Coexpression cluster:C3220: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C3220_Dendritic_Burkitt_thymus_CD4_CD34_lymphoma_CD8 |id=C3220 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C3220_Dendritic_Burkitt_thymus_CD4_CD34_lymphoma_CD8
|full_id=C3220_Dendritic_Burkitt_thymus_CD4_CD34_lymphoma_CD8
|id=C3220
|id=C3220
|ontology_enrichment_celltype=CL:0000037!3.80e-48!172;CL:0000566!3.80e-48!172;CL:0000988!6.93e-46!182;CL:0002032!1.49e-43!165;CL:0000837!1.49e-43!165;CL:0000738!1.52e-43!140;CL:0002087!1.47e-36!119;CL:0002031!1.48e-34!124;CL:0000542!8.06e-29!53;CL:0000051!8.06e-29!53;CL:0000838!3.43e-28!52;CL:0000763!7.46e-17!112;CL:0000049!7.46e-17!112;CL:0000084!1.12e-13!25;CL:0000827!1.12e-13!25;CL:0000945!1.14e-13!24;CL:0000826!1.14e-13!24;CL:0000766!1.17e-13!76;CL:0000791!8.75e-12!18;CL:0000789!8.75e-12!18;CL:0002420!8.75e-12!18;CL:0002419!8.75e-12!18;CL:0000790!8.75e-12!18;CL:0000557!2.17e-11!71;CL:0002009!3.87e-10!65;CL:0000236!1.57e-09!14;CL:0002194!2.11e-09!63;CL:0000576!2.11e-09!63;CL:0000040!2.11e-09!63;CL:0000559!2.11e-09!63;CL:0000839!2.82e-09!70;CL:0002057!6.72e-09!42;CL:0000860!3.01e-08!45;CL:0000134!1.18e-07!358;CL:0000625!1.54e-07!11;CL:0002320!7.52e-07!365;CL:0000219!9.35e-07!390
|ontology_enrichment_disease=DOID:2531!2.62e-10!51;DOID:0060083!2.62e-10!51;DOID:1240!2.51e-07!39
|ontology_enrichment_uberon=UBERON:0002390!3.80e-17!102;UBERON:0003061!3.80e-17!102;UBERON:0002193!6.74e-16!112;UBERON:0002371!8.28e-09!80;UBERON:0000178!3.35e-08!15;UBERON:0000179!3.35e-08!15;UBERON:0000463!3.35e-08!15;UBERON:0001474!1.10e-07!86;UBERON:0002405!2.89e-07!115
}}
}}

Revision as of 14:33, 21 May 2012


Full id: C3220_Dendritic_Burkitt_thymus_CD4_CD34_lymphoma_CD8



Phase1 CAGE Peaks

Hg19::chr12:104323463..104323474,-p@chr12:104323463..104323474
-
Hg19::chr12:110434021..110434034,-p7@GIT2
Hg19::chr12:110434043..110434066,-p3@GIT2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell3.80e-48172
angioblastic mesenchymal cell3.80e-48172
hematopoietic cell6.93e-46182
hematopoietic oligopotent progenitor cell1.49e-43165
hematopoietic multipotent progenitor cell1.49e-43165
leukocyte1.52e-43140
nongranular leukocyte1.47e-36119
hematopoietic lineage restricted progenitor cell1.48e-34124
lymphocyte8.06e-2953
common lymphoid progenitor8.06e-2953
lymphoid lineage restricted progenitor cell3.43e-2852
myeloid cell7.46e-17112
common myeloid progenitor7.46e-17112
T cell1.12e-1325
pro-T cell1.12e-1325
lymphocyte of B lineage1.14e-1324
pro-B cell1.14e-1324
myeloid leukocyte1.17e-1376
mature alpha-beta T cell8.75e-1218
alpha-beta T cell8.75e-1218
immature T cell8.75e-1218
mature T cell8.75e-1218
immature alpha-beta T cell8.75e-1218
granulocyte monocyte progenitor cell2.17e-1171
macrophage dendritic cell progenitor3.87e-1065
B cell1.57e-0914
monopoietic cell2.11e-0963
monocyte2.11e-0963
monoblast2.11e-0963
promonocyte2.11e-0963
myeloid lineage restricted progenitor cell2.82e-0970
CD14-positive, CD16-negative classical monocyte6.72e-0942
classical monocyte3.01e-0845
mesenchymal cell1.18e-07358
CD8-positive, alpha-beta T cell1.54e-0711
connective tissue cell7.52e-07365
motile cell9.35e-07390
Uber Anatomy
Ontology termp-valuen
hematopoietic system3.80e-17102
blood island3.80e-17102
hemolymphoid system6.74e-16112
bone marrow8.28e-0980
blood3.35e-0815
haemolymphatic fluid3.35e-0815
organism substance3.35e-0815
bone element1.10e-0786
immune system2.89e-07115
Disease
Ontology termp-valuen
hematologic cancer2.62e-1051
immune system cancer2.62e-1051
leukemia2.51e-0739


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.